110 related articles for article (PubMed ID: 17630106)
1. Immunohistochemical detection of X-linked inhibitor of apoptosis (XIAP) in neoplastic and other thyroid disorders.
Xiao GQ; Unger PD; Burstein DE
Ann Diagn Pathol; 2007 Aug; 11(4):235-40. PubMed ID: 17630106
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical detection of X-linked inhibitor of apoptosis in head and neck squamous cell carcinoma.
Nagi C; Xiao GQ; Li G; Genden E; Burstein DE
Ann Diagn Pathol; 2007 Dec; 11(6):402-6. PubMed ID: 18022123
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical detection of antiapoptotic protein X-linked inhibitor of apoptosis in mammary carcinoma.
Jaffer S; Orta L; Sunkara S; Sabo E; Burstein DE
Hum Pathol; 2007 Jun; 38(6):864-70. PubMed ID: 17350670
[TBL] [Abstract][Full Text] [Related]
4. Expression of p63 in papillary thyroid carcinoma and in Hashimoto's thyroiditis: a pathobiologic link?
Unger P; Ewart M; Wang BY; Gan L; Kohtz DS; Burstein DE
Hum Pathol; 2003 Aug; 34(8):764-9. PubMed ID: 14506636
[TBL] [Abstract][Full Text] [Related]
5. An immunohistochemical study of XIAP expression in pleomorphic adenoma and carcinoma ex pleomorphic adenoma.
Hoch BL; Wu M; Lewis M; Gan L; Burstein DE
J Oral Pathol Med; 2008 Nov; 37(10):634-8. PubMed ID: 18673415
[TBL] [Abstract][Full Text] [Related]
6. CD117 expression in normal, neoplastic, inflammatory, and reactive lesions of the thyroid.
Aydin O; Yildiz L; Kefeli M; Kandemir B
Pathol Res Pract; 2008; 204(6):359-65. PubMed ID: 18337018
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic utility of CD56 immunohistochemistry in papillary carcinoma of the thyroid.
El Demellawy D; Nasr AL; Babay S; Alowami S
Pathol Res Pract; 2009; 205(5):303-9. PubMed ID: 19153015
[TBL] [Abstract][Full Text] [Related]
8. Expression of ras oncogene p21 antigen in normal and proliferative thyroid tissues.
Johnson TL; Lloyd RV; Thor A
Am J Pathol; 1987 Apr; 127(1):60-5. PubMed ID: 3105323
[TBL] [Abstract][Full Text] [Related]
9. Expression of X-linked inhibitor of apoptosis protein in neoplastic thyroid disorder.
Yim JH; Yoon JH; Kim SA; Kim WG; Jeon MJ; Han JM; Sung TY; Kim TY; Kim WB; Hong SJ; Shong YK; Gong G
J Korean Med Sci; 2011 Sep; 26(9):1191-5. PubMed ID: 21935275
[TBL] [Abstract][Full Text] [Related]
10. Feasibility of immunocytochemical detection of tumor markers (XIAP, phosphohistone H1 and p63) in FNA cellblock samples from head and neck squamous cell carcinoma.
Wu M; Kafanas A; Gan L; Kohtz DS; Zhang L; Genden E; Burstein DE
Diagn Cytopathol; 2008 Nov; 36(11):797-800. PubMed ID: 18831009
[TBL] [Abstract][Full Text] [Related]
11. The expression and role of serum response factor in papillary carcinoma of the thyroid.
Kim HJ; Kim KR; Park HS; Jang KY; Chung MJ; Shong M; Moon WS
Int J Oncol; 2009 Jul; 35(1):49-55. PubMed ID: 19513551
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical detection of XIAP in mesothelium and mesothelial lesions.
Wu M; Sun Y; Li G; Desman G; Wang B; Gil J; Burstein DE
Am J Clin Pathol; 2007 Nov; 128(5):783-7. PubMed ID: 17951200
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical detection of p63 and XIAP in thymic hyperplasia and thymomas.
Wu M; Sun K; Gil J; Gan L; Burstein DE
Am J Clin Pathol; 2009 May; 131(5):689-93. PubMed ID: 19369629
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical detection of XIAP in melanoma.
Emanuel PO; Phelps RG; Mudgil A; Shafir M; Burstein DE
J Cutan Pathol; 2008 Mar; 35(3):292-7. PubMed ID: 18251743
[TBL] [Abstract][Full Text] [Related]
15. Utility of galectin 3 expression in thyroid aspirates as a diagnostic marker in differentiating benign from malignant thyroid neoplasms.
Aron M; Kapila K; Verma K
Indian J Pathol Microbiol; 2006 Jul; 49(3):376-80. PubMed ID: 17001889
[TBL] [Abstract][Full Text] [Related]
16. Cytokeratin 19 immunoreactivity in the diagnosis of papillary thyroid carcinoma: a note of caution.
Sahoo S; Hoda SA; Rosai J; DeLellis RA
Am J Clin Pathol; 2001 Nov; 116(5):696-702. PubMed ID: 11710686
[TBL] [Abstract][Full Text] [Related]
17. Thyroid peroxidase and galectin-3 immunostaining in differentiated thyroid carcinoma with clinicopathologic correlation.
Savin S; Cvejic D; Isic T; Paunovic I; Tatic S; Havelka M
Hum Pathol; 2008 Nov; 39(11):1656-63. PubMed ID: 18657294
[TBL] [Abstract][Full Text] [Related]
18. CD147 expression as a significant prognostic factor in differentiated thyroid carcinoma.
Tan H; Ye K; Wang Z; Tang H
Transl Res; 2008 Sep; 152(3):143-9. PubMed ID: 18774544
[TBL] [Abstract][Full Text] [Related]
19. Delta Np73 expression in thyroid neoplasms originating from follicular cells.
Ito Y; Uramoto H; Funa K; Yoshida H; Jikuzono T; Asahi S; Higashiyama T; Tomoda C; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Kuma K; Miyauchi A
Pathology; 2006 Jun; 38(3):205-9. PubMed ID: 16753740
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical analysis of nm23 protein expression in thyroid papillary carcinoma and follicular neoplasm.
Tabriz HM; Adabi Kh; Lashkari A; Heshmat R; Haghpanah V; Larijani B; Tavangar SM
Pathol Res Pract; 2009; 205(2):83-7. PubMed ID: 18996649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]